BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30980131)

  • 1. Efficacy of immunotherapy, gut microbiota and impact of antibiotic use: are there confounding factors?
    Milano G
    Cancer Chemother Pharmacol; 2019 Jul; 84(1):223-224. PubMed ID: 30980131
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the emerging role of the microbiome in cancer immunotherapy.
    Fessler J; Matson V; Gajewski TF
    J Immunother Cancer; 2019 Apr; 7(1):108. PubMed ID: 30995949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications.
    Guven DC; Aktas BY; Simsek C; Aksoy S
    Future Oncol; 2020 Mar; 16(9):497-506. PubMed ID: 32100550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gut microbiota and efficacy of cancer therapies].
    Vétizou M; Daillère R; Zitvogel L
    Biol Aujourdhui; 2017; 211(1):51-67. PubMed ID: 28682227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiome Modulates Response to Cancer Immunotherapy.
    Khan MAW; Ologun G; Arora R; McQuade JL; Wargo JA
    Dig Dis Sci; 2020 Mar; 65(3):885-896. PubMed ID: 32067144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of modulating the gastrointestinal microbiota in cancer patients.
    Morkūnas E; Skiecevičienė J; Kupčinskas J
    Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intimate relationship between gut microbiota and cancer immunotherapy.
    Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
    Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer.
    Iglesias-Santamaría A
    Clin Transl Oncol; 2020 Sep; 22(9):1481-1490. PubMed ID: 31919759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota Manipulated to Enhance Immunity.
    Cancer Discov; 2019 Jul; 9(7):822. PubMed ID: 31072874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gut Microbiota in Causation, Detection, and Treatment of Cancer.
    Murphy CL; OʼToole PW; Shanahan F
    Am J Gastroenterol; 2019 Jul; 114(7):1036-1042. PubMed ID: 30848738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity.
    Baiden-Amissah REM; Tuyaerts S
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pembrolizumab for the treatment of gastric cancer.
    Kamath SD; Kalyan A; Benson AB
    Expert Rev Anticancer Ther; 2018 Dec; 18(12):1177-1187. PubMed ID: 30280940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improving efficacy of cancer immunotherapy through targeting of macrophages].
    Peranzoni E; Donnadieu E
    Med Sci (Paris); 2019 Mar; 35(3):207-209. PubMed ID: 30931902
    [No Abstract]   [Full Text] [Related]  

  • 16. Gut microbiota modulation of chemotherapy efficacy and toxicity.
    Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
    Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure.
    Velikova T; Krastev B; Lozenov S; Gencheva R; Peshevska-Sekulovska M; Nikolaev G; Peruhova M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is gut microbiome a predictive marker to response to immune checkpoint inhibitors?
    Saleh K; Khalife-Saleh N; Kourie HR
    Immunotherapy; 2017 Sep; 9(11):865-866. PubMed ID: 29251088
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotics and the developing infant gut microbiota and resistome.
    Gibson MK; Crofts TS; Dantas G
    Curr Opin Microbiol; 2015 Oct; 27():51-6. PubMed ID: 26241507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Checkpoint Inhibitors: Conquering Cancer with a Little (T)-Help from Our Microbial Friends.
    Asmar N; Ibrahim T; Rey JF
    Dig Dis Sci; 2018 Sep; 63(9):2177-2179. PubMed ID: 29982987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.